n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid has been researched along with s-adenosyl-3-thiopropylamine in 2 studies
| Studies (n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid) | Trials (n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid) | Recent Studies (post-2010) (n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid) | Studies (s-adenosyl-3-thiopropylamine) | Trials (s-adenosyl-3-thiopropylamine) | Recent Studies (post-2010) (s-adenosyl-3-thiopropylamine) |
|---|---|---|---|---|---|
| 7 | 0 | 4 | 10 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bingham, P; Diehl, W; Gajiwala, K; Huang, B; Krivacic, C; Kung, PP; Maegley, KA; Tatlock, J; Yu, X; Zehnder, L | 1 |
| Fischer, TR; Helm, M; Hoba, SN; Jung, N; Kersten, C; Koch, J; Lyko, F; Meidner, JL; Schirmeister, T; Schwickert, M; Stark, MM; Weber, M; Windbergs, M; Zimmermann, RA | 1 |
2 other study(ies) available for n(4)-adenosyl-n(4)-methyl-2,4-diaminobutanoic acid and s-adenosyl-3-thiopropylamine
| Article | Year |
|---|---|
SAH derived potent and selective EZH2 inhibitors.
Topics: Dose-Response Relationship, Drug; Drug Design; Enhancer of Zeste Homolog 2 Protein; Humans; Models, Molecular; Molecular Structure; Polycomb Repressive Complex 2; S-Adenosylhomocysteine; Structure-Activity Relationship | 2015 |
Discovery of Inhibitors of DNA Methyltransferase 2, an Epitranscriptomic Modulator and Potential Target for Cancer Treatment.
Topics: Archaeal Proteins; Caco-2 Cells; DNA; Humans; Methyltransferases; Neoplasms; S-Adenosylhomocysteine; S-Adenosylmethionine | 2022 |